Acute Renal Colic. Unspecified renal colic
Conditions
Interventions
Intervention 1: 30mg Intravenous Ketorolac + 0.1 mg/kg Intravenous Morphine Sulphate. Intervention 2: 0.1 mg/kg Intravenous Morphine Sulphate. Intervention 3: 30mg Intravenous Ketorolac.
Treatment - Drugs
30mg Intravenous Ketorolac + 0.1 mg/kg Intravenous Morphine Sulphate
0.1 mg/kg Intravenous Morphine Sulphate
30mg Intravenous Ketorolac
Sponsors
Vice chancellor for research of Mazandaran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 55 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Age 18-55 years; Clinical diagnosis of acute renal colic (sudden sharp colic flank pain with or without radiation to genitalia or groin and with or without urinary symptoms); Pain score of 5 or more measured by 10-cm visual analogue scale (VAS). Exclusion criteria: history of kidney or renal dysfunction and severe dehydration; pregnancy; breastfeeding; single kidney or kidney transplantation; history of peptic ulcers and gastrointestinal bleeding; receiving analgesics within 6 hours before presentation; history of bleeding diathesis; history of cardiovascular disease and the use of angiotensin-converting-enzyme inhibitor (ACE inhibitor) or angiotensin receptor blockers (ARB); anticoagulant medication or coagulation disorders; history of drug dependence or current use of methadone or chronic consumption of tobacco and alcohol; peritonitis; presence of any peritoneal sign.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain. Timepoint: 0, 20 and 40 minutes. Method of measurement: Visual analogue scale. | — |
Secondary
| Measure | Time frame |
|---|---|
| Adverse effects. Timepoint: 0, 20 and 40 minutes. Method of measurement: Clinical examination. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMehran Amooei Khanabbasi
Mazandaran University of Medical Sciences
Outcome results
None listed